| Jorlis Medical Service Psc | |
|
16 Calle Rafael Ocasio Salinas PR 00751-3240 | |
| (787) 824-1934 | |
| Not Available |
| Full Name | Jorlis Medical Service Psc |
|---|---|
| Speciality | General Practice |
| Location | 16 Calle Rafael Ocasio, Salinas, Puerto Rico |
| Authorized Official Name and Position | Angel Luis Torres Martinez (ADMINISTRATOR) |
| Authorized Official Contact | 7878241934 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jorlis Medical Service Psc Po Box 700 Salinas PR 00751-0700 Ph: (787) 824-1934 | Jorlis Medical Service Psc 16 Calle Rafael Ocasio Salinas PR 00751-3240 Ph: (787) 824-1934 |
| NPI Number | 1437687084 |
|---|---|
| Provider Enumeration Date | 05/26/2017 |
| Last Update Date | 05/29/2023 |
| Medicare PECOS PAC ID | 4385003425 |
|---|---|
| Medicare Enrollment ID | O20230707000027 |
News Archive
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437687084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 10338 (Puerto Rico) | Primary |
| Provider Name | Jorge L Torres Martinez |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1619053956 PECOS PAC ID: 1557513645 Enrollment ID: I20121219000237 |
News Archive
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 5 days ago
| Provider Name | Noelis Torres Ortiz |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1396440830 PECOS PAC ID: 4587019401 Enrollment ID: I20231012003612 |
News Archive
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 5 days ago
| Provider Name | Arturo Cayere Morales |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1861718959 PECOS PAC ID: 5496102535 Enrollment ID: I20231109003891 |
News Archive
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 5 days ago
News Archive
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 5 days ago
Oscar J Rodriguez, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Carr. 701 Lote 1, Bo. Playa, Salinas, PR 00751 Phone: 787-824-4562 | |
Gastro Sur Psc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Porto Fino Plaza Carr #3 Km 158.7, Salinas, PR 00751 Phone: 787-239-7850 Fax: 866-325-4826 | |
Farmacia Gs, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 26 Calle Monserrate, Salinas, PR 00751 Phone: 787-824-4444 | |
Sur-med Medical Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8 Colon Pacheco St, Salinas, PR 00751 Phone: 787-824-7097 Fax: 787-824-7655 | |
Medical Group A&k Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Baldorioty #56, Salinas, PR 00751 Phone: 787-558-7888 Fax: 787-824-7242 | |
Centro De Servicios Primarios De Salud De Patillas Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Calle Barbosa #114 Esq. Diosdado Dones, Comunidad El Coco Barrio Lapa, Salinas, PR 00751 Phone: 787-839-4320 Fax: 787-839-4320 |